Biotech Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation November 2, 2026
Biotech HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan November 1, 2026
Biotech Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026 October 31, 2026
Biotech Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities October 31, 2026
Biotech Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia October 31, 2026
Biotech Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. October 30, 2026